OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spontaneous Activity of CB2 Receptors Attenuates Stress-Induced Behavioral and Neuroplastic Deficits in Male Mice
Melissa A. Ribeiro, Rafael Pazinatto Aguiar, Franciele Franco Scarante, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 15

Showing 15 citing articles:

Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review
Nastaran Talaee, Shataw Azadvar, Sanaz Khodadadi, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 7, pp. 983-1016
Closed Access | Times Cited: 8

Cannabinoid receptor 2 agonist AM1241 alleviates epileptic seizures and epilepsy-associated depression via inhibiting neuroinflammation in a pilocarpine-induced chronic epilepsy mouse model
Yiying Cai, Fangchao Tong, Kexian Li, et al.
Molecular and Cellular Neuroscience (2024) Vol. 130, pp. 103958-103958
Closed Access | Times Cited: 3

Neural plasticity and depression treatment
Yubing Wang, Ning‐Ning Song, Yu‐Qiang Ding, et al.
IBRO Neuroscience Reports (2022) Vol. 14, pp. 160-184
Open Access | Times Cited: 15

Cannabinoid type 2 receptor inhibition enhances the antidepressant and proneurogenic effects of physical exercise after chronic stress
Rui S. Rodrigues, João B. Moreira, Joana M. Mateus, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Exploring the Therapeutic Potential of Terpenoids for Depression and Anxiety
Arif Azimi Md Noor
Chemistry & Biodiversity (2024)
Closed Access | Times Cited: 1

Putative Pharmacological Depression and Anxiety-Related Targets of Calcitriol Explored by Network Pharmacology and Molecular Docking
Bruna R. Kouba, Glorister A. Altê, Ana Lúcia S. Rodrigues
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 893-893
Open Access | Times Cited: 1

PPARγ Dysfunction in the Medial Prefrontal Cortex Mediates High-Fat Diet-Induced Depression
Congcong Fu, Xinyi Zhang, Xu Liu, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 7, pp. 4030-4043
Closed Access | Times Cited: 7

Anxiogenic doses of rapamycin prevent URB597-induced anti-stress effects in socially defeated mice
Eduardo J. Fusse, Franciele Franco Scarante, Maria Adrielle Vicente, et al.
Neuroscience Letters (2023) Vol. 818, pp. 137519-137519
Closed Access | Times Cited: 2

Genetic ablation of the isoform γ of PI3K decreases antidepressant efficacy of ketamine in male mice.
Gabriela Neves Vaz, Flávia Turcato, Isabel Lima, et al.
IBRO Neuroscience Reports (2024) Vol. 17, pp. 87-95
Open Access

The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress
Melissa A. Ribeiro, Rafael Pazinatto Aguiar, Franciele Franco Scarante, et al.
Behavioural Brain Research (2023) Vol. 450, pp. 114502-114502
Closed Access

Cannabinoid type 2 receptor inhibition enhances the antidepressant and proneurogenic effects of physical exercise after chronic stress
Rui S. Rodrigues, J.A. Moreira, Sandra H. Vaz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top